Indication
Opioid-induced respiratory depression
Opioid-induced respiratory depression is a potentially fatal adverse effect and medical emergency characterized by significant central nervous system and ventilatory suppression following exposure to opioid agonists. Read more about Opioid-induced respiratory depression
57 drugs 49 manufacturers
Drugs that treat it
Common Opioid-induced respiratory depression therapies.
NALOXONE HCL
NALOXONE HCL
NALOXONE HCL
NALOXONE HCL
NALOXONE HCL
NALOXONE HCL
EVZIO (naloxone HCl)
NALOXONE (naloxone HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOpioid-induced respiratory depression is a potentially fatal adverse effect and medical emergency characterized by significant central nervous system and ventilatory suppression following exposure to opioid agonists.
Pathophysiologically, it occurs when opioids activate mu-opioid receptors within respiratory control networks of the brainstem, specifically dampening neural rhythmogenesis in the pre-Bötzinger complex and blunting central and peripheral chemoreceptor sensitivity to rising hypercapnia and hypoxia.
Clinically, affected patients exhibit hypoventilation characterized by markedly decreased respiratory rate, shallow breathing, periodic apnea, and progressive central nervous system sedation, which leads to severe hypoxemia, respiratory acidosis, and potential cardiac arrest if left uncorrected.
- nih.gov
Opioid-induced respiratory depression is a potentially fatal adverse effect and medical emergency characterized by significant central nervous system and ventilatory suppression following exposure to opioid agonists
- apsf.org
Opioid-induced respiratory depression is a potentially fatal adverse effect and medical emergency characterized by significant central nervous system and ventilatory suppression following exposure to opioid agonists Clinically, affected patients exhibit hypoventilation characterized by markedly decreased respiratory rate, shallow breathing, periodic apnea, and progressive central nervous system sedation, which leads to severe hypoxemia, respiratory acidosis, and potential cardiac arrest if left ...
- nih.gov
Pathophysiologically, it occurs when opioids activate mu-opioid receptors within respiratory control networks of the brainstem, specifically dampening neural rhythmogenesis in the pre-Bötzinger complex and blunting central and peripheral chemoreceptor sensitivity to rising hypercapnia and hypoxia
- nih.gov
Pathophysiologically, it occurs when opioids activate mu-opioid receptors within respiratory control networks of the brainstem, specifically dampening neural rhythmogenesis in the pre-Bötzinger complex and blunting central and peripheral chemoreceptor sensitivity to rising hypercapnia and hypoxia Clinically, affected patients exhibit hypoventilation characterized by markedly decreased respiratory rate, shallow breathing, periodic apnea, and progressive central nervous system sedation, which lead...
- wustl.edu
Pathophysiologically, it occurs when opioids activate mu-opioid receptors within respiratory control networks of the brainstem, specifically dampening neural rhythmogenesis in the pre-Bötzinger complex and blunting central and peripheral chemoreceptor sensitivity to rising hypercapnia and hypoxia
- clevelandclinic.org
Clinically, affected patients exhibit hypoventilation characterized by markedly decreased respiratory rate, shallow breathing, periodic apnea, and progressive central nervous system sedation, which leads to severe hypoxemia, respiratory acidosis, and potential cardiac arrest if left uncorrected
Personalize your experience
Follow Opioid-induced respiratory depression and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.